首页> 美国卫生研究院文献>Research Involvement and Engagement >Taking patient reported outcomes centre stage in cancer research – why has it taken so long?
【2h】

Taking patient reported outcomes centre stage in cancer research – why has it taken so long?

机译:以患者报告的结局为癌症研究的中心阶段–为什么花了这么长时间?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Plain English summaryRoger Wilson challenged cancer professionals in research and care to place the patient perspective and patient reported outcome measures centre stage. The ability to collect information from patients using structured questionnaires (known as Patient Reported Outcome Measures or PROMs) which ask about clinical issues (such as disease symptoms or treatment side-effects) as well as social, emotional and psychological issues has existed for 40 years. They provide a powerful way of working out whether an aspect of diagnosis or treatment for cancer is bringing real benefits to patients that can be measured using these structured questionnaires. When they are used, studies and cancer service developments are clearly constrained to focus on what matters to patients rather than, perhaps what matters to health service professionals or recent exciting but perhaps relatively unproven new technologies. There is good evidence that PROMs can contribute valuable inputs into the results of randomised controlled trials, clinical consultations and surveys of whole populations even at a national level. However, there is a great deal more work to be done on methodology and perhaps to change attitudes and cultures within the healthcare professions before they can deliver all of their potential to bring benefits to cancer patients.
机译:简单的英语摘要罗杰·威尔逊(Roger Wilson)挑战了癌症专业人士的研究和护理工作,以患者观点和患者报告的结局指标为中心。使用结构化问卷(称为“患者报告的结果指标”或“ PROM”)从患者那里收集信息的能力已经存在了40年,该问卷询问了临床问题(例如疾病症状或治疗副作用)以及社会,情感和心理问题。它们提供了一种强有力的方法来确定癌症的诊断或治疗方面是否正在为患者带来实际利益,可以使用这些结构化问卷进行衡量。当使用它们时,研究和癌症服务的发展显然受到限制,只能集中在对患者重要的方面,而不是对健康服务专业人员重要的方面或最近令人兴奋但相对未经验证的新技术。有充分的证据表明,即使在国家一级,PROM也可以为随机对照试验,临床咨询和整个人群的调查结果提供有价值的投入。但是,在方法论上还有很多工作要做,也许还需要改变医疗保健行业的态度和文化,然后他们才能发挥全部潜能为癌症患者带来益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号